Dermatology Collaboration and Licensing Deals Report, 2016 to 2024, Featuring 600+ Companies and 400+ Deals
02 mai 2024 07h33 HE
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Dermatology Collaboration and...
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
01 mai 2024 16h01 HE
|
Journey Medical Corporation
SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
Kamari Pharma Appoints Dr. John Doux to its Board of Directors
30 avr. 2024 09h00 HE
|
Kamari Pharma
NESS ZIONA, Israel, April 30, 2024 (GLOBE NEWSWIRE) -- Kamari Pharma, a privately-held clinical stage biotechnology company developing first and best-in-class treatments for rare and severe genetic...
Europe Scar Management Market Analysis Report 2024: A $350+ Million Market by 2030 with Advancis Medical, Bayer, B. Braun, Molnlycke Health Care, Smith & Nephew, and Stratpharma Dominating
29 avr. 2024 10h07 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Europe Scar Management Market: Analysis and Forecast, 2023-2030" report has been added to ResearchAndMarkets.com's offering. The Europe scar...
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
25 avr. 2024 08h30 HE
|
Journey Medical Corporation
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
Global Skin Allergy Testing Market Report 2024-2028 with Analysis of Companies' Market Shares, Proprietary Technologies, Alliances and Patents
24 avr. 2024 06h14 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Global Skin Allergy Testing Market" report has been added to ResearchAndMarkets.com's offering.The global market for skin allergy testing is expected...
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
17 avr. 2024 10h15 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...
Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology
16 avr. 2024 16h05 HE
|
Kamari Pharma
Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
16 avr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the...
EveLab Insight Furthers Its Reach into the European Market at Cosmoprof Bologna
10 avr. 2024 09h30 HE
|
EveLab Insight
EveLab Insight built further inroads into the European market at Cosmoprof Bologna.